Lacrimal Gland Tumors Treatment in India is provided by interdisciplinary teams of specialists and delivers top-quality oncologists service combined with an active commitment to personalized care in an ambience of comfort and convenience. Hospitals catering
Lacrimal Gland Tumors Treatment in India provide
intensive care and the on-call medical, surgical and anesthetic teams and patients therefore benefit from both the advantages of private care and the reassurance and safety provided by full back-services.
Indian Medical tourism work only with the finest private hospitals and surgeons
to give best results for treatment of
Lacrimal Gland Tumors Treatment in India and to bring you the best medical care according to highest international standards.
What are Lacrimal Gland Tumors?
The
Lacrimal Glands tumors are the glands that secrete tears and are located above and to the side of the eye. When
Lacrimal Glands cells become abnormal and start to multiply, they form a growth of tissue called a tumor. A
Lacrimal Glands tumors can be benign (noncancerous) or malignant (cancerous, meaning it can spread to other parts of the body). There are four major types of
Lacrimal Glands tumors:
- Benign mixed epithelial tumor: A benign mixed epithelial tumor is a noncancerous tumor that does not spread to other parts of the body but will continue to grow if not treated. This type of tumor begins in the cells that line the Lacrimal Gland.
- Malignant mixed epithelial tumor: A malignant mixed epithelial tumor also begins in the cells that line the Lacrimal Glands. If it is not treated, it will spread to other parts of the body.
- Lymphoma: It can involve various structures of the eye; however, the conjunctiva (the mucous membrane lining the inner surfaces of the eyelids and the outer surface of the white of the eye) and Lacrimal Glands are the most common. Most ocular (eye-related) lymphoma is non-Hodgkin lymphoma, and may be associated with systemic or central nervous system lymphoma. Read more about non-Hodgkin lymphoma.
- Adenoid cystic carcinoma (AdCC) of the lacrimal gland: AdCC is a rare form of adenocarcinoma, which is a broad term covering any cancer arising from glandular tissues. An AdCC tumor is characterized by a distinctive pattern, in which bundles of epithelial cells surround and/or infiltrate ducts or glandular structures within the organ. When an AdCC tumor of the Lacrimal Glands grows, it commonly pushes the eye forward and causes it to bulge, a condition called proptosis. Another characteristic is pain, due to local nerves being invaded by the tumor. Read more about adenoid cystic carcinoma.
Lacrimal Gland Tumors Symptoms
People with
Lacrimal Glands tumors may experience the
symptoms or signs. Sometimes people with
Lacrimal Glands tumors do not show any of these
symptoms. Or, these symptoms may be similar to symptoms of other medical conditions. If you are concerned about a symptom or sign on this list, please talk with your ophthalmologist (a medical doctor who specializes in eye care).
- Vision problems, such as blurry vision
- Pain in or around the eye
- A fullness of the eyelid, or a mass that can be felt on the eyelid
- Swelling around the eye
- Double vision
Lacrimal Gland Tumors Diagnosis
Doctors use many tests to
diagnose Lacrimal Glands tumors and find out if it has metastasized (spread). Some tests may also determine which treatments may be the most effective. For most types of tumors, a biopsy is the only way to make a definitive diagnosis of cancer. If a biopsy is not possible, the doctor may suggest other tests that will help make a diagnosis. Imaging tests may be used to find out whether the cancer has metastasized. Your doctor may consider these factors when choosing a diagnostic test:
- Age and medical condition
- The type of tumor suspected
- Severity of symptoms
- Previous test results
In addition to a physical examination, the following tests may be used for
Lacrimal Glands tumors diagnosis:
- Biopsy.
- Computed tomography (CT or CAT) scan
- Magnetic resonance imaging (MRI)
- Positron emission tomography (PET) scan
- Bone scan
Lacrimal Glands tumors Staging and Grading
Staging is a way of describing a tumor, such as where it is located, if it is cancerous, if or where it has spread, and if it is affecting the functions of other organs in the body. Doctors use diagnostic tests to determine the tumors stage, so staging may not be complete until all the tests are finished. Knowing the stage helps the doctor to decide what kind of treatment is best and can help predict a patient's prognosis (chance of recovery). There are different stage descriptions for different types of tumors.
The staging below describes
Lacrimal Gland carcinomas. For more information on the staging of ocular non-Hodgkin lymphoma, see the Guide to Non-Hodgkin Lymphoma.
One tool that doctors use to describe the stage of a
Lacrimal Gland tumor is the TNM system. This system uses three criteria to judge the stage of the disease: the tumor itself, the lymph nodes around the tumor, and if the tumor has spread to the rest of the body. The results are combined to determine the stage for each person. There are five stages: stage 0 (zero) and stages I through IV (one through four). The stage provides a common way of describing the disease so doctors can work together to plan the best treatments. Not all doctors may use this staging system for
Lacrimal Gland tumour; talk with your doctor for more information about staging.
TNM is an abbreviation for tumor (T), node (N), and metastasis (M). Doctors look at these three factors to determine the stage:
- How large is the primary tumor and where is it located? (Tumor, T)
- Has the tumor spread to the lymph nodes? (Node, N)
- Has the cancer metastasized to other parts of the body? (Metastasis, M)
Tumor. Using the TNM system, the "T" plus a letter and/or number (0 to 4) is used to describe the size and location of the tumor. Some stages are also divided into smaller groups that help describe the tumor in even more detail. Specific tumor stage information is listed below:
TX: The primary tumor cannot be evaluated.
T0: There is no tumor.
T1: The tumor is 2 centimeters (cm) or smaller and may or may not extend outside of the
Lacrimal Gland to the orbital soft tissue.
T2: The tumor is between 2 cm and 4 cm and likely extends to the orbital soft tissue.
T3: The tumor is greater than 4 cm and likely extends to the orbital soft tissue.
T4: The tumor has invaded the periosteum (the membrane of connective tissue that covers the bone) or the orbital bone.
T4a: The tumor has invaded the periosteum.
T4b: The tumor has invaded the orbital bone.
T4c: The tumor has extended beyond the orbit to adjacent structures, including the brain and sinuses.
Node. The N in the TNM staging system stands for lymph nodes, the tiny, bean-shaped organs that help fight infection. Lymph nodes near the
Lacrimal Gland are called regional lymph nodes. Lymph nodes in other parts of the body are called distant lymph nodes.
NX: The regional lymph nodes cannot be evaluated.
N0 (N plus zero): There is no regional lymph node metastasis.
N1: There is regional lymph node metastasis.
Distant metastasis. The M in the TNM system indicates whether the cancer has spread from the
Lacrimal Glands to other parts of the body.
MX: Distant metastasis cannot be evaluated.
M0 (M plus zero): There is no distant metastasis.
M1: There is metastasis to other parts of the body.
Histologic grade. Histologic grade describes how closely the tumor cells resemble normal tissue under a microscope. A tumor's grade is described using the letter G and a number.
GX: The tumor grade cannot be identified.
G1: Describes cells that look more like normal tissue cells (well differentiated).
G2: The cells are somewhat different (moderately differentiated).
G3: The tumor cells look very much alike (poorly differentiated).
G4: The cells barely resemble normal cells (undifferentiated).
Lacrimal Glands tumors Treatment
The
Lacrimal Gland Tumors Treatment depends on the size and location of the tumor, whether one or both eyes are involved, if the tumor is cancerous, whether the cancer has spread, and the person's overall health. In many cases, a team of doctors may work with the patient to determine the best treatment plan. Goals of
Lacrimal Gland Tumors Treatment include complete removal of the tumor, as well as maintaining the health and vision of the patients eye.
This section outlines
Lacrimal Gland Tumors Treatments that are the standard of care (the best treatments available) for this specific type of tumor. Patients are also encouraged to consider clinical trials as a treatment option when making treatment plan decisions. A clinical trial is a research study to test a new treatment to prove it is safe, effective, and possibly better than standard treatment. Your doctor can help you review all treatment options. For more information, visit theClinical Trials section. Descriptions of the most common treatment options for
Lacrimal Gland Tumors Treatment are listed below:
Surgery: Surgery to the eye is quite common
Lacrimal Gland Tumors Treatments. During surgery, the ophthalmologist will remove parts of the affected eye or, if necessary, the entire eye (enucleation), depending on the size and spread of the tumor. Possible side effects of eye surgery are similar to that of any surgery, including a risk of infection, problems with anesthesia (medication used during surgery to block sensation and pain impulses along the nerve pathways to the brain), and pain.
Radiation therapy: Radiation therapy is the use of high-energy x-rays or other particles to kill cancer cells. It is most often used for
Lacrimal Gland Tumors Treatment. A doctor who specializes in giving radiation therapy to treat cancer is called a radiation oncologist. A radiation therapy regimen (schedule) usually consists of a specific number of treatments given over a specific time. There are different types of radiation therapy. The most common type of radiation treatment is called external-beam radiation therapy, which is radiation given from a machine outside the body. Proton therapy (also called proton beam therapy) is a type of external-beam radiation therapy that uses protons rather than x-rays. At high energy, protons can destroy cancer cells. Learn more about proton therapy.
Intensity modulated radiation therapy (IMRT) is another way to deliver external-beam radiation therapy. The intensity is varied to more precisely target the tumor, and therefore damages less surrounding healthy tissue than is possible with traditional radiation treatment. IMRT may also reduce the damage to nearby important organs.
The dosage of radiation used and the site and type of the tumor significantly affect the risks of side effects. Cataracts are a very common side effect of radiation therapy to the eye area. A cataract is opacity (a lack of transparency) of the lens or capsule of the eye. People with cataracts may have cloudy or foggy vision, have trouble seeing at night, and/or have problems with glare from the sun or bright lights. If the cataract is causing major problems with a person's eyesight, the cataract can be surgically removed. Also, loss of eyelashes and/or a dry eye can occur with external-beam radiation therapy. Other side effects from radiation therapy may include fatigue, mild skin reactions, upset stomach, and loose bowel movements. Most side effects go away soon after treatment is finished. Other possible side effects are more uncommon. Radiation retinopathy is the development of abnormal blood vessels in the retina. Radiation optic neuropathy involves nerve damage in the eye. Neovascular glaucoma is a painful condition in which new blood vessels develop and block the regular release of fluid from the eye. If there is significant damage to the eye from radiation therapy, the eye may need to be removed.
Chemotherapy: Chemotherapy is the use of drugs to kill
Lacrimal Gland Tumors cells. Systemic chemotherapy is delivered through the bloodstream, targeting tumor cells throughout the body. Chemotherapy is given by a medical oncologist, a doctor who specializes in treating a tumor with medication. Some people may receive chemotherapy in their doctors office or outpatient clinic; others may go to the hospital. A chemotherapy regimen (schedule) usually consists of a specific number of cycles given over a specific time.
The side effects of chemotherapy depend on the individual and the dose used, but can include fatigue, risk of infection, nausea and vomiting, loss of appetite, and diarrhea. These side effects usually go away once treatment is finished. Learn more about chemotherapy and preparing for treatment. The medications used to treat cancer are continually being evaluated. Talking with your doctor is often the best way to learn about the medications prescribed for you, their purpose, and their potential side effects or interactions with other medications. Learn more about your prescriptions by using searchable drug databases.
Immunotherapy: (also called biologic therapy) is designed to boost the body's natural defenses to fight the
Lacrimal Gland Tumors. It uses materials either made by the body or in a laboratory to bolster, target, or restore immune system function. Rituximab (Rituxan) is the most common immunotherapy used in the treatment of a
Lacrimal Gland Tumors and is used for the treatment of non-Hodgkin lymphoma.
Why in Lacrimal Gland Tumors Treatment in India?
Lacrimal Gland Tumors Treatment in India at cancer centers of India is very popular as facilities provided are comparable with other major hospital world-wide and the quality of surgery is much better as compared to west. Medical tourism in
India makes continuous efforts to help foreign patients receive world-class medical treatments at almost zero waiting periods. Medical tourism in
India provides a combination of high-class medicine with the luxurious ambience of hotel-style accommodation, the perfect service of all-round care forms for international patients.
For more information on
Lacrimal Gland Tumors Treatment in India, visit us at
www.forerunnershealthcare.com or mail your queries at
enquiry@forerunnershealthcare.com or call us at: +91-9371136499, +91- 9860755000 (International) / + 1-415-599-2537 (USA) / +44-20-8133-2571 (UK).
Important Links:
Visit Website:
Forerunners Health Care
Send Queries
Watch International Patient Video
